Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR | P25105 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL9854098 | 0.85 | PTAFR (0.58) | PTAFRTBXAS1 | |
| SCHEMBL9853993 | 0.85 | PTAFR (0.57) | PTAFRTBXAS1 | |
| SCHEMBL9854076 | 0.85 | PTAFR (0.57) | PTAFRTBXAS1 | |
| SCHEMBL9854020 | 0.85 | PTAFR (0.67) | PTAFRTBXAS1 | |
| SCHEMBL9854077 | 0.83 | PTAFR (0.58) | PTAFRSMN1; SMN2TBXAS1 | |
| SCHEMBL9854024 | 0.83 | PTAFR (0.68) | PTAFRTBXAS1 | |
| SCHEMBL9853930 | 0.83 | PTAFR (0.64) | PTAFRTBXAS1 | |
| SCHEMBL9853988 | 0.83 | PTAFR (0.55) | PTAFRTBXAS1 | |
| SCHEMBL9854088 | 0.83 | PTAFR (0.55) | PTAFRTBXAS1 | |
| SCHEMBL9853959 | 0.82 | PTAFR (0.55) | PTAFRLMNAHTTGAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0425134-A1 | Condensed pyrrolo derivatives, process for their preparation and pharmaceutical compositions containing them | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1991-05-02 | — | — | EP | disclosed |